TheStreet's Adam Feuerstein gazes into his crystal ball to offer his biotechnology forecast for the new year.
But expect the Affordable Care Act and prescriber pushback to curb drug-pricing power.
Next-gen drugs can help power growth and income alike.
Vivus shares dropped after it reported weaker-than-expected sales of its weight loss drug.
Interest rate decisions are expected today from the European Central Bank and Bank of England.
Investors, traders are bound to follow the extremely tight presidential race as the day unfolds.
Analyst predicts it will take time, however, before Qsymia records meaningful revenue.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.